J. Stern & Co’s DexCom DXCM Stock Holding History

J. Stern & Co’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.9M	Buy	28,232 +1,568	+6%	+$104K	0.18%	32
2026 Q1	$1.67M	Buy	26,664 +2,527	+10%	+$176K	0.16%	33
2025 Q4	$1.6M	Sell	24,137 -48,195	-67%	-$3.12M	0.14%	33
2025 Q3	$4.87M	Buy	72,332 +32,284	+81%	+$2.55M	0.37%	34
2025 Q2	$3.38M	Buy	40,048 +2,372	+6%	+$186K	0.29%	25
2025 Q1	$2.57M	Buy	37,676 +10,051	+36%	+$820K	0.25%	28
2024 Q4	$2.15M	Buy	27,625 +4,187	+18%	+$310K	0.2%	29
2024 Q3	$1.57M	Buy	23,438 +12,557	+115%	+$1.03M	0.17%	29
2024 Q2	$1.23M	Buy	10,881 +8,394	+338%	+$1.06M	0.15%	25
2024 Q1	$345K	Buy	2,487 +1,145	+85%	+$144K	0.04%	25
2023 Q4	$163K	Buy	+1,342	New	+$137K	0.03%	33

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

J. Stern & Co's DXCM Position: Q2 2026 in Review

J. Stern & Co increased its DexCom (DXCM) stake by 5.9% in Q2 2026, buying an estimated $104K and bringing the position to 28,232 shares worth $1.9M. The position accounts for 0.18% of the portfolio, ranked #32.

J. Stern & Co first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.87M in Q3 2025. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

J. Stern & Co held 28,232 shares of DexCom worth $1.9M as of Q2 2026.
J. Stern & Co bought 1,568 DexCom shares in Q2 2026, an estimated $104K.
DexCom made up 0.18% of J. Stern & Co's portfolio in Q2 2026, its #32 holding.
J. Stern & Co first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
J. Stern & Co's DexCom position peaked at $4.87M in Q3 2025.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on J. Stern & Co's 13F filing for Q2 2026, filed 14 Aug 2026.